Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3  Wendy Chang, M.D.,

Slides:



Advertisements
Similar presentations
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Advertisements

Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the.
Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practice  Lysanne.
Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome  Anuja Dokras, M.D., Ph.D., Shailly Saini,
Selective impairment in glycogen synthase kinase-3 and mitogen-activated protein kinase phosphorylation: comparisons with the hyperandrogenic and the.
The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study  Jeff G. Wang, M.D., Richard A. Anderson,
Age at menarche: a predictor of diminished ovarian function?
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis  Héctor F. Escobar-Morreale, M.D., Ph.D., Manuel Luque-Ramírez,
Daily physical activity and hot flashes in the Study of Women's Health Across the Nation (SWAN) Flashes Study  Carolyn Gibson, M.P.H., M.S., Karen Matthews,
Comparison of hormonal and metabolic markers after a high-fat, Western meal versus a low-fat, high-fiber meal in women with polycystic ovary syndrome 
MRNA expression pattern of insulin-like growth factor components of granulosa cells and cumulus cells in women with and without polycystic ovary syndrome.
Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women  Babak Mokhlesi, M.D.,
Kalliopi Kotsa, M. D. , Ph. D. , Maria P. Yavropoulou, M. D
Michael M. Alper, M.D.  Fertility and Sterility 
Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters  Enrico Carmina, M.D., Francesco.
Michal Youngster, M. D. , Valerie L. Ward, M. D. , M. P. H. , Emily A
Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome  Anuja Dokras, M.D., Ph.D., Shailly Saini,
Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study  Cem Celik, M.D., Nicel.
The spectrum of androgen excess disorders
Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome 
Insulin resistance in oligomenorrheic infertile women with non-polycystic ovary syndrome  Shirei Ohgi, M.D., Koji Nakagawa, M.D., Ph.D., Rieko Kojima,
Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study  Angela Kerchner, B.A., Whitney Lester,
Polycystic ovary syndrome: an ancient disorder?
Lauren Groskaufmanis, M.P.H., Saba W. Masho, M.D. 
Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels 
Shahin Ghadir, M.D., Ricardo Azziz, M.D., M.P.H., M.B.A. 
Study of circulating hepcidin in association with iron excess, metabolic syndrome, and BMP-6 expression in granulosa cells in women with polycystic ovary.
Expression of growth differentiation factor-9 and bone morphogenetic protein-15 in oocytes and cumulus granulosa cells of patients with polycystic ovary.
Rebecca A. Feldman, M. D. , Kathleen O'Neill, M. D. , Samantha F
Functional neuroimaging of emotional processing in women with polycystic ovary syndrome: a case-control pilot study  Courtney A. Marsh, M.D., M.P.H.,
Role of androgen-mediated enhancement of erythropoiesis in the increased body iron stores of patients with polycystic ovary syndrome  Héctor F. Escobar-Morreale,
Evolutionary determinants of polycystic ovary syndrome: part 1
Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis 
Clinical course of depression symptoms and predictors of enduring depression risk in women with polycystic ovary syndrome: Results of a longitudinal study 
Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the.
Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens 
The determinants of insulin sensitivity, β-cell function, and glucose tolerance are different in patients with polycystic ovary syndrome than in women.
Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin action  Vanita Aroda, M.D., Theodore.
Andrew C. Bjonnes, M.S., Richa Saxena, Ph.D., Corrine K. Welt, M.D. 
Serum luteinizing hormone levels are markedly increased and significantly correlated with Δ4-androstenedione levels in lean women with polycystic ovary.
Hyperglycemia Stimulates Activation of Nuclear Factor κB (NFκB) in Mononuclear Cells (MNC) of Women With Polycystic Ovary Syndrome (PCOS)  F. Gonzalez,
Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity  Jean-Patrice Baillargeon, M.D.,
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Increased secretion of amylin in women with polycystic ovary syndrome
Prevalence of polycystic ovary syndrome in adolescents
Fleur R. Cattrall, M. B. B. S. , Beverley J. Vollenhoven, M. B. B. S
Antoni J. Duleba, M.D., Ibrahim M. Ahmed, M.D.  Fertility and Sterility 
Metformin reduces serum müllerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment  Richard Fleming, Ph.D.,
Banu Ucar, M. D. , Volkan Noyan, M. D. , Osman Caglayan, M. D
Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial  Antoni J. Duleba, M.D.,
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Manuel Maliqueo, Ph. D. , Bárbara Echiburú, Ph. D
Paolo Moghetti, M.D.  Fertility and Sterility 
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Rupal Shroff, B. S. , Craig H. Syrop, M. D. , William Davis, M. D
Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome:
Increased total and phosphorylated glycogen synthase kinase-3 (GSK-3) in the adipocytes of patients with the polycystic ovary syndrome (PCOS)  W.Y. Chang,
Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions  Kristen Farrell, M.S.,
Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome  Yuwen Wu, M.D., Jianhua Zhang,
Inappropriate gonadotropin secretion in polycystic ovary syndrome
Tsan-Hon Liou, M. D. , Ph. D. , Jen-Hung Yang, M. D. , Ph. D
Aline Ketefian, M. D. , Jianfang Hu, Ph. D. , Alfred A. Bartolucci, Ph
Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome 
Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation  Reshef.
Adiponectin levels reflect the different phenotypes of polycystic ovary syndrome: study in normal weight, normoinsulinemic patients  Artemis Karkanaki,
Decrease in adiponectin levels in women with polycystic ovary syndrome after an oral glucose tolerance test  Dimitrios Panidis, M.D., Ph.D., Dimitrios.
Androgen responses to adrenocorticotropic hormone infusion among individual women with polycystic ovary syndrome  Kevin H. Maas, M.D., Ph.D., Sandy Chuan,
Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis 
Is there a role for diet in ameliorating the reproductive sequelae associated with chronic low-grade inflammation in polycystic ovary syndrome and obesity? 
Marita Pall, M. D. , Ph. D. , Margaret Nguyen, B. S
Presentation transcript:

Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3  Wendy Chang, M.D., Mark O. Goodarzi, M.D., Ph.D., Heith Williams, M.S., Denis A. Magoffin, Ph.D., Marita Pall, M.D., Ph.D., Ricardo Azziz, M.D., M.B.A., M.P.H.  Fertility and Sterility  Volume 90, Issue 6, Pages 2291-2297 (December 2008) DOI: 10.1016/j.fertnstert.2007.10.025 Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Glucose uptake in adipocytes from control women and women with PCOS. 3-O-methyl glucose uptake was measured in freshly prepared adipocytes from six women with PCOS and four control women. Data are presented as the ratio of stimulated glucose uptake to the basal glucose uptake to control for individual subject variation in basal uptake. ∗Significant increases within groups. a = P<.05 vs. PCOS; b = P<.01 vs. PCOS. Fertility and Sterility 2008 90, 2291-2297DOI: (10.1016/j.fertnstert.2007.10.025) Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Assessment of GSK3 phosphorylation. (A) Serine phosphorylation of GSK3α in response to insulin was significant in control women (blue bars; P=.028) but not in women with PCOS (red bars; P=.058). (B) Serine phosphorylation of GSK3β in PCOS did not respond to insulin stimulation (P=.51), whereas within control women, insulin led to increased phosphorylation (P=.028). (C) Levels of tyrosine-phosphorylated GSK3β were increased in women with PCOS, both at baseline and with insulin stimulation, compared with the case in control women (P=.0015). Levels of phosphoproteins are presented normalized to the expression levels of the corresponding total protein. Error bars = SE. Fertility and Sterility 2008 90, 2291-2297DOI: (10.1016/j.fertnstert.2007.10.025) Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions